Jack H Dean insider trades: Acurx Pharmaceuticals (ACXP) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jack reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | ACXP | ↑ Buy | 9,852 | $1.01 | $10K | Direct | Jan 8, 2025 (2d) |
| May 21, 2014 | DPRX | ↑ Buy | 3,000 | $9.00 | $27K | Direct | May 22, 2014 (1d) |
| Mar 18, 2014 | DPRX | ↑ Buy | 2,083 | $12.00 | $25K | Direct | Mar 20, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jack H Dean's insider trades
Jack H Dean is a director at Acurx Pharmaceuticals (ACXP). Since Mar 18, 2014, Jack has reported 3 open-market purchases worth $62K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ACXP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.